Literature DB >> 15674657

Association between IFNA genotype and the risk of systemic lupus erythematosus.

Hitoshi Nakashima1, Sawako Matsuno, Mitsuteru Akahoshi, Katsuhisa Miyake, Yasushi Inoue, Yosuke Tanaka, Ichiro Ninomiya, Sakiko Shimizu, Takashi Igawa, Atsushi Sadanaga, Takeshi Otsuka, Mine Harada.   

Abstract

Systemic lupus erythematosus (SLE) is characterized by multisystem inflammation and production of autoantibodies, which can generate immune complexes and may cause tissue damage through the recognition of an autoantigen. Although many factors have been proposed, such as genetic factors, environmental factors, hormonal action, viruses, and dysregulation of cytokine production, the cause of this disease is not well understood. It has been reported that the levels of interferon (IFN)-alpha in the sera of some SLE patients are elevated and that IFN-alpha induces maturation of monocytes into highly active antigen-presenting dendritic cells (DCs). We analyzed the association between IFN-alpha genotype and the risk of SLE to clarify whether IFN-alpha plays a central role in susceptibility to SLE. The results showed that no IFN-alpha genotype was significantly associated with the risk of SLE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15674657     DOI: 10.1007/s10067-004-0966-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

1.  Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: a case report and review of the literature.

Authors:  S Fukuyama; E Kajiwara; N Suzuki; N Miyazaki; S Sadoshima; K Onoyama
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

Review 2.  Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy.

Authors:  Y Ioannou; D A Isenberg
Journal:  Arthritis Rheum       Date:  2000-07

Review 3.  Type I interferons.

Authors:  E De Maeyer; J De Maeyer-Guignard
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

4.  Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

Authors:  P Blanco; A K Palucka; M Gill; V Pascual; J Banchereau
Journal:  Science       Date:  2001-11-16       Impact factor: 47.728

Review 5.  Delineating the genetic basis of systemic lupus erythematosus.

Authors:  E K Wakeland; K Liu; R R Graham; T W Behrens
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

6.  Polymorphism in the interferon-alpha gene family.

Authors:  I Golovleva; M Kandefer-Szerszen; L Beckman; E Lundgren
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

7.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.

Authors:  Emily C Baechler; Franak M Batliwalla; George Karypis; Patrick M Gaffney; Ward A Ortmann; Karl J Espe; Katherine B Shark; William J Grande; Karis M Hughes; Vivek Kapur; Peter K Gregersen; Timothy W Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

8.  Association between IFNA genotype and the risk of sarcoidosis.

Authors:  Mitsuteru Akahoshi; Mami Ishihara; Natascha Remus; Kazuko Uno; Katsuhisa Miyake; Tomomitsu Hirota; Kazuko Nakashima; Akira Matsuda; Mizuo Kanda; Tadao Enomoto; Shigeaki Ohno; Hitoshi Nakashima; Jean-Laurent Casanova; Julian M Hopkin; Mayumi Tamari; Xiao-Quan Mao; Taro Shirakawa
Journal:  Hum Genet       Date:  2004-03-05       Impact factor: 4.132

Review 9.  The evolution of the type I interferons.

Authors:  R M Roberts; L Liu; Q Guo; D Leaman; J Bixby
Journal:  J Interferon Cytokine Res       Date:  1998-10       Impact factor: 2.607

10.  Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.

Authors:  Lynda Bennett; A Karolina Palucka; Edsel Arce; Victoria Cantrell; Josef Borvak; Jacques Banchereau; Virginia Pascual
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

View more
  1 in total

Review 1.  The genetics and epigenetics of autoimmune diseases.

Authors:  Anura Hewagama; Bruce Richardson
Journal:  J Autoimmun       Date:  2009-04-05       Impact factor: 7.094

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.